title: Development and initial testing of a permanently implantable centrifugal pump.
abstract: To be able to salvage heart failure patients, the need for an economical permanent ventricular assist device is increasing. To meet this increasing demand, a miniaturized centrifugal blood pump has been developed as a permanently implantable device. The Gyro permanently implantable model (PI-601) incorporates a sealless design with a blood stagnation free structure. The pump impeller is magnetically coupled to the driver magnet in a sealless manner. This pump is atraumatic and antithrombogenic and incorporates a double pivot bearing system. A miniaturized actuator was utilized in this system in collaboration with the University of Vienna. The priming volume of this pump is 20 ml. The overall size of the pump actuator package is 53 mm in height and 65 mm in diameter, 145 ml of displacement volume, and 305 g in weight. Testing to date has included in vitro hydraulic performance and hemolysis. This pump can provide 5 L/min against a 110 mm Hg total pressure head at 2,000 rpm and 8 L/min against 150 mm Hg at 2,500 rpm. The normalized index of hemolysis (NIH) value of this pump was 0.0028 g/100 L at 5 L/min against 100 mm Hg. A preliminary anatomical study revealed the possibility of the implantability of 2 such systems in biventricular bypass at a preperitoneal location. This system is feasible for use as a permanently implantable biventricular assist device.
authors.affiliation: Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.
authors.forename: T
authors.initials: T
authors.lastname: Nakazawa
authors.forename: Y
authors.initials: Y
authors.lastname: Takami
authors.forename: R
authors.initials: R
authors.lastname: Benkowski
authors.forename: S
authors.initials: S
authors.lastname: Ohtsubo
authors.forename: O
authors.initials: O
authors.lastname: Yukio
authors.forename: E
authors.initials: E
authors.lastname: Tayama
authors.forename: G
authors.initials: G
authors.lastname: Ohtsuka
authors.forename: Y
authors.initials: Y
authors.lastname: Niimi
authors.forename: J
authors.initials: J
authors.lastname: Glueck
authors.forename: A
authors.initials: A
authors.lastname: Sueoka
authors.forename: H
authors.initials: H
authors.lastname: Schmallegger
authors.forename: H
authors.initials: H
authors.lastname: Schima
authors.forename: E
authors.initials: E
authors.lastname: Wolner
authors.forename: Y
authors.initials: Y
authors.lastname: Nosé
mesh_terms: D000818:Animals; D001672:Biocompatible Materials / Q000627:therapeutic use; D002417:Cattle; D002498:Centrifugation; D003362:Cost-Benefit Analysis; D004574:Electromagnetic Fields; D005240:Feasibility Studies; D005260:Female; D006333:Heart Failure / Q000628:therapy; D006353:Heart-Assist Devices / Q000009:adverse effects / Q000191:economics / Q000592:standards; D019736:Prostheses and Implants
chemical_list: D001672:Biocompatible Materials